Which treatments had been tapered or stopped in rheumatoid arthritis in long-term DAS28 remission following subcutaneous tumor-necrosis-factor blocker therapy? A retrospective experience on 43 patients

2012 ◽  
Vol 79 (5) ◽  
pp. 520-521
Author(s):  
Sanae Ali Ou Alla ◽  
Cedric Lukas ◽  
Najia Hajjaj-Hassouni ◽  
René Marc Flipo ◽  
Bernard Combe ◽  
...  
Keyword(s):  
Rheumatoid Arthritis ◽  
Tumor Necrosis Factor ◽  
Tumor Necrosis ◽  
Blocker Therapy ◽  
Subcutaneous Tumor ◽  
Tumor Necrosis Factor Blocker ◽  
Das28 Remission ◽  
Necrosis Factor

Long-term Survival of Subcutaneous Anti-tumor Necrosis Factor Biological Drugs Administered Between 2008 and 2012 in a Cohort of Rheumatoid Arthritis Patients

2019 ◽  
Vol 15 (1) ◽  
pp. 54-57
Author(s):  
Noelia Alvarez Rivas ◽  
Tomas R. Vazquez Rodriguez ◽  
Jose A. Miranda Filloy ◽  
Carlos Garcia-Porrua ◽  
Amalia Sanchez-Andrade Fernández
Keyword(s):  
Rheumatoid Arthritis ◽  
Tumor Necrosis Factor ◽  
Tumor Necrosis ◽  
Biological Drugs ◽  
Term Survival ◽  
Long Term Survival ◽  
Necrosis Factor

scholarly journals Can very high-dose anti-tumor necrosis factor blockade at onset of rheumatoid arthritis produce long-term remission?

2002 ◽  
Vol 46 (7) ◽  
pp. 1971-1972 ◽  
Author(s):  
Philip G. Conaghan ◽  
Mark A. Quinn ◽  
Philip O'Connor ◽  
Richard J. Wakefield ◽  
Zunaid Karim ◽  
...  
Keyword(s):  
Rheumatoid Arthritis ◽  
Tumor Necrosis Factor ◽  
Tumor Necrosis ◽  
High Dose ◽  
Very High ◽  
Necrosis Factor
Sign in / Sign up

Export Citation Format

Share Document